Segment Reporting - Schedule of Segment Information (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|||||||||||
| Schedule of Segment Information [Abstract] | ||||||||||||||||
| Research and development | $ 233,665 | $ 381,061 | $ 1,010,075 | $ 909,746 | $ 1,849,996 | $ 3,190,293 | ||||||||||
| Sales and marketing | 5,813 | 68,834 | 10,091 | 137,825 | 189,470 | 571,040 | ||||||||||
| General and administrative | 1,243,778 | 851,195 | 2,636,838 | 1,722,801 | 3,723,635 | 7,055,814 | ||||||||||
| Total operating expenses | 1,483,256 | 1,301,090 | 3,657,004 | 2,770,372 | 5,763,101 | 10,817,147 | ||||||||||
| Operating loss | (1,483,256) | (1,301,090) | (3,657,004) | (2,770,372) | (5,763,101) | (10,817,147) | ||||||||||
| Other segment items | 1,643,200 | [1] | 75,178 | [1] | 2,505,515 | [1] | 508,130 | [1] | (1,264,309) | [2] | (690,800) | [2] | ||||
| Net income/(loss) | 159,944 | (1,225,912) | (1,151,489) | (2,262,242) | (7,027,410) | (11,507,947) | ||||||||||
| Reconciliation of net loss | ||||||||||||||||
| Adjustments and reconciling items | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Consolidated net income/(loss) | $ 159,944 | $ (1,225,912) | $ (1,151,489) | $ (2,262,242) | $ (7,027,410) | $ (11,507,947) | ||||||||||
| ||||||||||||||||
| X | ||||||||||
- Definition Amount of net loss consolidated. No definition available.
|
| X | ||||||||||
- Definition Amount of other segment items. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) and loss (gain) in reconciling net income to reflect cash provided by (used in) operating activity when indirect cash flow method is applied. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|